Deep Brain Stimulation In Parkinsons Disease Market, By Product (Single-channel and Dual-channel), By End-use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4316
|
Published Date
August 2025
|
Pages
288
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Deep Brain Stimulation In Parkinson’s Disease Market size was valued at US$ 910.28 Million in 2024, expanding at a CAGR of 10.30% from 2025 to 2032.
The Deep Brain Stimulation (DBS) market for Parkinson’s disease encompasses the global industry focused on devices, technologies, and services used in DBS therapy to treat Parkinson’s disease. DBS involves the surgical implantation of electrodes into targeted regions of the brain, delivering controlled electrical impulses to manage motor symptoms such as tremors, stiffness, and bradykinesia that are not sufficiently controlled by medication. The market includes implantable pulse generators (IPGs), electrodes, stimulation programming software, and post-implantation support services.
Globally, governments are increasingly recognizing the burden of Parkinson’s disease and supporting advanced treatment options like DBS. According to the World Health Organization, the number of people living with Parkinson’s is expected to exceed 12 million by 2040, prompting many countries to enhance funding and healthcare policies for neurological disorders. These initiatives are driving adoption of DBS therapies and expanding the market worldwide.
Deep Brain Stimulation In Parkinson’s Disease Market- Market Dynamics
Rising Prevalence of Neurological Disorders Drives Market Growth
The increasing prevalence of neurological disorders is expected to significantly drive growth in the Deep Brain Stimulation (DBS) market for Parkinson’s disease in the coming years. Neurological disorders encompass a wide range of conditions affecting the autonomic, peripheral, and central nervous systems. DBS systems are employed in neurosurgical procedures to deliver targeted electrical stimulation, aiming to modulate neural activity and provide a reversible, adjustable, and therapeutic effect.
For example, the Parkinson’s Foundation, a US-based national organization, reported that nearly 90,000 people were diagnosed with Parkinson’s disease in the United States in March 2023—representing a 50% increase from the previous estimate of 60,000 annual diagnoses. This rising prevalence of neurological disorders is a key factor propelling the expansion of the Deep Brain Stimulation market for Parkinson’s disease.
Deep Brain Stimulation In Parkinson’s Disease Market- Segmentation Analysis:
The Global Deep Brain Stimulation In Parkinson’s Disease Market is segmented on the basis of Product, End-use, and Region.
The deep brain stimulation (DBS) market is segmented into two product types: Single-channel and Dual-channel devices. The dual-channel segment is expected to account for the largest market share in 2025, owing to its superior effectiveness in reducing patient tremors and enhancing overall quality of life. Dual-channel DBS systems offer greater control and precision by delivering targeted electrical stimulation to specific brain regions, which has made them the preferred choice among neurosurgeons and patients. Their robust performance, reliability, and advanced functionality have solidified their leadership position in the market. According to the National Institute of Neurological Disorders and Stroke (NINDS), over 160,000 patients worldwide have received DBS therapy, with dual-channel devices increasingly favored for their improved therapeutic outcomes.
Based on end-use, the DBS market is categorized into Hospitals, Ambulatory Surgical Centers, Neurology Clinics, and Research Centers, with hospitals expected to dominate in 2025. Hospitals are typically equipped with advanced medical technology and specialized healthcare professionals, enabling them to provide comprehensive care for patients undergoing DBS therapy. Given the complexity of the DBS procedure and the need for continuous patient monitoring and support, many patients prefer receiving treatment in hospital settings. Hospitals also offer a multidisciplinary approach involving neurologists, neurosurgeons, and other specialists, which enhances patient outcomes through coordinated care. The Centers for Disease Control and Prevention (CDC) reports that Parkinson’s disease affects nearly one million people in the United States alone, many of whom require ongoing management that hospitals are uniquely equipped to provide.
Deep Brain Stimulation In Parkinson’s Disease Market- Geographical Insights
North America is expected to hold the largest revenue share in the Deep Brain Stimulation (DBS) market for Parkinson’s disease in 2025. The region’s dominance is driven by several factors, including a high prevalence of Parkinson’s disease, advanced healthcare infrastructure, and substantial government and private funding for research and development. Additionally, technological advancements such as robot-assisted implantation and improved microelectrode designs have further accelerated market growth in North America.
The Asia Pacific DBS market for Parkinson’s disease is anticipated to experience the fastest growth during the forecast period. This rapid expansion is attributed to the rising prevalence of Parkinson’s disease, increasing healthcare expenditures, and growing awareness of DBS therapy. The region also benefits from technological innovations and the launch of new DBS devices. Furthermore, governments across Asia Pacific are promoting the adoption of DBS treatments through favorable policies and increased funding for research and development.
Deep Brain Stimulation In Parkinson’s Disease Market- Competitive Landscape:
The DBS market is driven by several major medical device companies investing heavily in research and development to innovate and improve patient outcomes. Market leaders differentiate themselves by offering advanced technologies and patient-centric solutions, creating a moderately consolidated competitive landscape. However, emerging startups and new entrants are intensifying competition and accelerating technological advancements in DBS systems.
Key players in the market include Medtronic, Boston Scientific, and Abbott, each boasting extensive portfolios of neurostimulation devices and a strong global presence. Medtronic, one of the largest DBS manufacturers, offers systems featuring adaptive stimulation and MRI compatibility. The company maintains its competitive edge through continuous innovation and collaborations with research institutions. Boston Scientific is also prominent, developing cutting-edge DBS technologies to address diverse patient needs.
Recent Developments:
- In August 2024, Medtronic plc received FDA approval for its Asleep DBS surgery procedure for Parkinson’s and essential tremor patients. This novel approach allows patients to undergo DBS surgery while either awake or asleep, enhancing patient comfort and surgical flexibility.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- Boston Scientific Corporation
- Medtronic
- Others
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Single-channel
- Dual-channel
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Ambulatory Surgical Centers
- Neurology Clinics
- Research Centers
GLOBAL DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Deep Brain Stimulation In Parkinson’s Disease Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Deep Brain Stimulation In Parkinson’s Disease Market Snippet by Product
2.1.2. Deep Brain Stimulation In Parkinson’s Disease Market Snippet by End-use
2.1.3. Deep Brain Stimulation In Parkinson’s Disease Market Snippet by Country
2.1.4. Deep Brain Stimulation In Parkinson’s Disease Market Snippet by Region
2.2. Competitive Insights
3. Deep Brain Stimulation In Parkinson’s Disease Key Market Trends
3.1. Deep Brain Stimulation In Parkinson’s Disease Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Deep Brain Stimulation In Parkinson’s Disease Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Deep Brain Stimulation In Parkinson’s Disease Market Opportunities
3.4. Deep Brain Stimulation In Parkinson’s Disease Market Future Trends
4. Deep Brain Stimulation In Parkinson’s Disease Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Deep Brain Stimulation In Parkinson’s Disease Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Deep Brain Stimulation In Parkinson’s Disease Market Landscape
6.1. Deep Brain Stimulation In Parkinson’s Disease Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Deep Brain Stimulation In Parkinson’s Disease Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Single-channel
7.1.3. Dual-channel
8. Deep Brain Stimulation In Parkinson’s Disease Market – By End-use
8.1. Overview
8.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
8.1.2. Hospitals
8.1.3. Ambulatory Surgical Centers
8.1.4. Neurology Clinics
8.1.5. Research Centers
9. Deep Brain Stimulation In Parkinson’s Disease Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Deep Brain Stimulation In Parkinson’s Disease Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Deep Brain Stimulation In Parkinson’s Disease Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.7. UK
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.7.4. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.8. France
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.8.4. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.9. Italy
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.9.4. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.10. Spain
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.10.4. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.11. The Netherlands
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.11.4. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.12. Sweden
9.3.12.1. Overview
9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.12.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.13. Russia
9.3.13.1. Overview
9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.13.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Deep Brain Stimulation In Parkinson’s Disease Key Manufacturers in Asia Pacific
9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.5. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.6. China
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.6.4. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.7. India
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.7.4. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.11. Indonesia
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.11.4. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.12. Thailand
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.12.4. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5. Latin America (LATAM)
9.5.1. Overview
9.5.2. Deep Brain Stimulation In Parkinson’s Disease Key Manufacturers in Latin America
9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.5. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa (MEA)
9.6.1. Overview
9.6.2. Deep Brain Stimulation In Parkinson’s Disease Key Manufacturers in Middle East and Africa
9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.5. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.7. UAE
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.7.4. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Deep Brain Stimulation In Parkinson’s Disease Industry
10.1. Competitive Benchmarking
10.1.1. Competitive Dashboard
10.1.2. Competitive Positioning
10.2. Company Profiles
10.2.1. Abbott
10.2.2. Boston Scientific Corporation
10.2.3. Medtronic
10.2.4. Others
11. 360 Degree AnalystView
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
